These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4289223)

  • 1. The sedimentation behavior of rhinovirus neutralizing activity in nasal secretion and serum following the rhinovirus common cold.
    Rossen RD; Douglas G; Cate TR; Couch RB; Butler WT
    J Immunol; 1966 Oct; 97(4):532-8. PubMed ID: 4289223
    [No Abstract]   [Full Text] [Related]  

  • 2. Rhinovirus neutralizing antibody in tears, parotid saliva, nasal secretions and serum.
    Douglas RG; Rossen RD; Butler WT; Couch RB
    J Immunol; 1967 Aug; 99(2):297-303. PubMed ID: 4166403
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of the neutralizing activity in nasal wash and serum following intranasal vaccinaion with inactivated type 13 rhinovirus.
    Knopf HL; Perkins JC; Bertran DM; Kapikian AZ; Chanock RM
    J Immunol; 1970 Mar; 104(3):566-73. PubMed ID: 4314177
    [No Abstract]   [Full Text] [Related]  

  • 4. An ELISA for the detection of rhinovirus specific antibody in serum and nasal secretion.
    Barclay WS; Al-Nakib W
    J Virol Methods; 1987 Jan; 15(1):53-64. PubMed ID: 3027117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody to rhinovirus in human sera. II. Heterotypic responses.
    Fleet WF; Douglas RG; Cate TR; Couch RB
    Proc Soc Exp Biol Med; 1968 Feb; 127(2):503-9. PubMed ID: 4296291
    [No Abstract]   [Full Text] [Related]  

  • 6. Mediators of immediate hypersensitivity in nasal secretions during natural colds and rhinovirus infection.
    Eggleston PA; Hendley JO; Gwaltney JM
    Acta Otolaryngol Suppl; 1984; 413():25-35. PubMed ID: 6099951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Occurrence of neutralizing antibodies against equine rhinovirus (strain NM 11) in horse stocks in Berlin].
    Teufel P; Keller H
    Berl Munch Tierarztl Wochenschr; 1970 Dec; 83(23):466-7. PubMed ID: 4322035
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemagglutination-inhibiting and neutralizing antibodies to type 3 and 5 rhinoviruses in human sera and nasal washings.
    Strízová V; Hrusková J; Syrücek L; Brücková M; Berkovicová V
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):348-52. PubMed ID: 231069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dietary supplementation with conjugated linoleic acid on experimental human rhinovirus infection and illness.
    Peterson KM; O'Shea M; Stam W; Mohede IC; Patrie JT; Hayden FG
    Antivir Ther; 2009; 14(1):33-43. PubMed ID: 19320235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental rhinovirus infection in human volunteers exposed to ozone.
    Henderson FW; Dubovi EJ; Harder S; Seal E; Graham D
    Am Rev Respir Dis; 1988 May; 137(5):1124-8. PubMed ID: 2461669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nasal secretion and serum antibody in the rhinovirus common cold.
    Cate TR; Rossen RD; Douglas RG; Butler WT; Couch RB
    Am J Epidemiol; 1966 Sep; 84(2):352-63. PubMed ID: 4288191
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contamination of the population with rhinovirus type 1A, 1B and 7].
    Mentel R; Oberender H; Schmidt J
    Z Gesamte Hyg; 1971 Sep; 17(9):676-8. PubMed ID: 4333182
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness.
    Perkins JC; Tucker DN; Knopf HL; Wenzel RP; Kapikian AZ; Chanock RM
    Am J Epidemiol; 1969 Dec; 90(6):519-26. PubMed ID: 4312066
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychological stress and the common cold.
    Gwaltney JM; Hayden FG
    N Engl J Med; 1992 Feb; 326(9):644-5; author reply 645-6. PubMed ID: 1310349
    [No Abstract]   [Full Text] [Related]  

  • 15. The time course of the humoral immune response to rhinovirus infection.
    Barclay WS; al-Nakib W; Higgins PG; Tyrrell DA
    Epidemiol Infect; 1989 Dec; 103(3):659-69. PubMed ID: 2558033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial.
    Sperber SJ; Hendley JO; Hayden FG; Riker DK; Sorrentino JV; Gwaltney JM
    Ann Intern Med; 1992 Jul; 117(1):37-41. PubMed ID: 1317694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemagglutination-inhibition test in rhinovirus infections of volunteers.
    Reed SE; Hall TS
    Infect Immun; 1973 Jul; 8(1):1-3. PubMed ID: 4352454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of illness from rhinovirus infection by a topical interferon inducer.
    Panusarn C; Stanley ED; Dirda V; Rubenis M; Jackson GG
    N Engl J Med; 1974 Jul; 291(2):57-61. PubMed ID: 4365144
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold.
    Avila PC; Abisheganaden JA; Wong H; Liu J; Yagi S; Schnurr D; Kishiyama JL; Boushey HA
    J Allergy Clin Immunol; 2000 May; 105(5):923-32. PubMed ID: 10808173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds.
    Turner RB; Weingand KW; Yeh CH; Leedy DW
    Clin Infect Dis; 1998 Apr; 26(4):840-6. PubMed ID: 9564459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.